Overview

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that increased dosages of mycophenolic acid in maintenance kidney transplant recipients may cause a reduction in donor-specific antibodies.
Phase:
Phase 4
Details
Lead Sponsor:
East Carolina University
Collaborator:
Novartis Pharmaceuticals
Treatments:
Antibodies
Immunoglobulins
Mycophenolate mofetil
Mycophenolic Acid